Team:Queens Canada/Project/Repel

From 2013.igem.org

(Difference between revisions)
 
(27 intermediate revisions not shown)
Line 65: Line 65:
     <div class="header-logo">
     <div class="header-logo">
     <img src="https://static.igem.org/mediawiki/2013/c/c7/Projct.png" style="height:80px;" />
     <img src="https://static.igem.org/mediawiki/2013/c/c7/Projct.png" style="height:80px;" />
 +
  <a href="https://igem.org/Main_Page">
 +
                <img src="https://static.igem.org/mediawiki/2013/4/46/Igem_qgem_logo.png" class="img-circle" style="height:60px;min-width:60px;float:right;"></a>
     </div>
     </div>
</div>
</div>
Line 106: Line 108:
         </div>
         </div>
         <div class="span4 project-buttons overview">
         <div class="span4 project-buttons overview">
-
                 <a class="test" href="https://2013.igem.org/Team:Queens_Canada/Project">OVERVIEW</a>
+
                 <a class="test" href="https://2013.igem.org/Team:Queens_Canada/Project/Overview">OVERVIEW</a>
         </div>
         </div>
         <div class="span4 project-buttons attract">
         <div class="span4 project-buttons attract">
Line 118: Line 120:
<div class="row-fluid">
<div class="row-fluid">
-
         <div class="offset1 span10 content">
+
         <div class="offset1 span10 content" style="text-align:justify;">
-
         Our idea for a mosquito repellent is to neutralize the odours that mosquitoes are attracted to. Recent studies have shown that malarial mosquitoes rely 4x more heavily on their sense of smell to find their prey. By removing the volatile compounds that cause these smells, we are effectively able to decrease the ability of mosquitoes to find humans. To achieve this end, we have created a genetic and enzymatic pathway. It begins with the uptake of isovaleric acid, the smell inducing compound, and converts it into a pleasant banana odour. Domestically, this serves as a foot deodorant but on a global scale it may also curb malaria rates.  
+
         Our idea of a mosquito repellent aims to neutralize the odours that mosquitoes are attracted to. Recent studies have shown that mosquitoes infected with the malarial parasite, <i>Plasmodium falciparum</i>, are four times more attracted to foot odour than non-infected mosquitoes. By removing the volatile compounds that cause these smells, we hypothesize that this will effectively decrease the ability of mosquitoes to find humans. Our project thus focuses on creating a genetic and enzymatic pathway to remove those volatile compounds. It begins with the uptake of isovaleric acid, a known mosquito semiochemical that is present is foot odour, and converts it into banana smell. Domestically, this serves as a foot deodorant but on a global scale it may also curb malaria infection rates.  
         </div>
         </div>
</div>
</div>
Line 130: Line 132:
<div class="row-fluid">
<div class="row-fluid">
-
         <div class="offset1 span10" style="margin-top:40px;"><span class="rose" style="font-size:1.5em">AtoE</span></div>
+
         <div class="offset1 span10" style="margin-top:20px;margin-bottom:10px;"><span class="rose" style="font-size:1.5em">AtoE</span></div>
</div>
</div>
<div class="row-fluid">
<div class="row-fluid">
-
         <div class="offset1 span10 content">
+
         <div class="offset1 span8 content" style="text-align:justify;">
-
         AtoE is a membrane transporter of short chain fatty acids. This gene is normally expressed in E. coli but in our project, the plan is to constitutively express this gene such that it is constantly uptaking surrounding isovaleric acid. Once within the bacteria, other reactions ensue.  
+
         AtoE is a non-specific membrane transporter of short-chain fatty acids endogenously expressed in ''E.coli''. High constitutive expression of this gene would allow high intake of surrounding isovaleric acid and channelling into the breakdown pathway.
-
        </div>
+
<br><br>
 +
In order to isolate the gene from the <i>E. coli</i> genome, we designed PCR primers so that the AtoE gene could be replicated with the correct biobrick prefix and suffix. The size of the AtoE gene is 1323 bp, but with the addition of the standard biobrick cut sites (43bp), a 1.4kb band was expected and was seen on the gel of the PCR products (<i>on right</i>).  
 +
        </div>
 +
        <div class="span3">
 +
                <img style="height:250px;text-align:center;" src="https://static.igem.org/mediawiki/2013/5/5c/AtoE_PCR_product.png"/>
 +
        </div>
</div>
</div>
<div class="row-fluid">
<div class="row-fluid">
-
         <div class="offset1 span10" style="margin-top:40px;"><span class="rose" style="font-size:1.5em">NCAR and NPT</span></div>
+
         <div class="offset1 span10" style="margin-top:20px;margin-bottom:10px;"><span class="rose" style="font-size:1.5em">NCAR and NPT</span></div>
</div>
</div>
<div class="row-fluid">
<div class="row-fluid">
-
         <div class="offset1 span10 content">
+
         <div class="offset1 span8 content" style="text-align:justify;">
-
         Carboxylic acid reductase (CAR) is an enzyme that converts fatty acids such as isovaleric into aldehydes. Phosphopantetheinyl transferase (NPT) is an enzyme that induces a post-translational modification by adding a pantetheinyl arm to the active site of the carboxylic acid reductase, which is crucial for the formation of a thioester intermediate.  
+
         Carboxylic acid reductase (CAR) and phosphopantetheinyl transferase (NPT) are endogenously expressed in <i>Nocardia iowensis</i>. NCAR is a highly non-specific carboxylic acid reductase that converts fatty acids such as isovaleric acid into aldehydes. NPT is an enzyme that induces a post-translational modification by adding a pantetheinyl arm to the active site of the carboxylic acid reductase, which is crucial for the formation of a thioester intermediate. NCAR was <a href="http://parts.igem.org/Part:BBa_K902062:Design">submitted</a> as a single part by Calgary iGEM 2012, but it is dependent on NPT for full function. We thus sought to link these two enzymes together to improve Calgary's part.  
-
        </div>
+
<br>
 +
</div>
 +
        <div class="span3">
 +
                <img style="height:300px;text-align:center;" src="https://static.igem.org/mediawiki/2013/8/8f/Ncar_npt.png"/>
 +
        </div>
</div>
</div>
<div class="row-fluid">
<div class="row-fluid">
-
         <div class="offset1 span10" style="margin-top:40px;"><span class="rose" style="font-size:1.5em">YjgB</span></div>
+
         <div class="offset1 span10" style="margin-top:20px;margin-bottom:10px;"><span class="rose" style="font-size:1.5em">YjgB</span></div>
</div>
</div>
<div class="row-fluid">
<div class="row-fluid">
-
         <div class="offset1 span10 content">
+
         <div class="offset1 span6 content" style="text-align:justify;">
-
         YjgB is a catalytic enzyme that converts aldehyde into alcohol.
+
         YjgB is a non-specific zinc-containing alcohol dehydrogenase endogenously expressed in <i>E. coli</i>. It reduces a number of different aldehydes to their corresponding alcohol using NADPH as a co-substrate. In this instance, we planned to use yjgB to reduce isoamyl aldehyde to isoamyl alcohol. We were successful in amplifying yjgB by PCR, cloning it into pSB1C3 with a high constitutive expression cassette, producing high concentrations of protein at the predicted size of 36kDa on an SDS PAGE gel. We verified our biobrick before sending it into the registry and found the sequence to be an exact match for the putative sequence from GenBank. Over the next week we will be using mass spectrometry and an NADPH activity assay to verify the amino acid sequence of the part and quantify its specific activity towards isobutyraldehyde. This is the part we have submitted this year. More details on this can be found on the <a href="https://2013.igem.org/Team:Queens_Canada/Parts">Parts</a> page on the wiki.  
         </div>
         </div>
-
</div>
+
<div class="span4"><img style = "height:300px;" src="https://static.igem.org/mediawiki/2013/0/06/Screen_Shot_2013-09-27_at_5.51.53_PM.png" style="height:500px;margin-top:30px;"></div></div>
<div class="row-fluid">
<div class="row-fluid">
-
         <div class="offset1 span10" style="margin-top:40px;margin-bottom:40px;"><span class="rose" style="font-size:1.5em">ATF1</span></div>
+
         <div class="offset1 span10" style="margin-top:20px;margin-bottom:10px;"><span class="rose" style="font-size:1.5em">ATF1</span></div>
</div>
</div>
<div class="row-fluid">
<div class="row-fluid">
-
         <div class="offset1 span10 content" style="margin-bottom:40px;">
+
         <div class="offset1 span7 content" style="margin-bottom:60px;text-align:justify;">
-
        Acetyl transferase 1 (ATF1) was a BioBrick created by MIT in 2006 as part of their iGEM project. It is derived from Saccharomyces cerevisiae and it catalyzes the conversion of isoamyl alcohol to isoamyl acetate, a compound that gives off a banana scent. This is the final step of our pathway, completing the neutralization of isovaleric acid.  
+
Alcohol acetyl-transferase 1 (ATF1) (<a href="http://parts.igem.org/Part:BBa_J45014">BBa_J45014</a>) is an enzyme endogenous to <i>Saccharomyces cerevisiae</i> and was first used by MIT iGEM 2006. It catalyzes the conversion of isoamyl alcohol to isoamyl acetate, which has a banana smell. This will complete the neutralization of isovaleric acid. We received the ATF1 gene from the Biobrick registry where we transformed and cut the part to be placed in with other genes in our pathway.
-
        </div>
+
<br>
 +
</div>
 +
        <div class="span4">
 +
                <img style="height:300px;text-align:center;" src="https://static.igem.org/mediawiki/2013/f/fa/ATF_gel.png"/>
 +
        </div>
</div>
</div>
<div class="row-fluid">
<div class="row-fluid">
-
<div class="offset2 span8" id="sponsorship-large">
+
        <div class="offset1 span10" style="margin-top:20px;margin-bottom:10px;text-align:justify;"><span class="rose" style="font-size:1.5em">Testing Isovaleric Acid</span></div>
-
    <div id="sponsorship-text" class="black" style="font-size:1.1em;">A huge thanks to our sponsors:</div>
+
</div>
-
        <div id="sponsorship-small">
+
<div class="row-fluid">
-
                <img style="height:130px;" src="https://static.igem.org/mediawiki/2013/f/f1/Queens_logo.jpg" />
+
        <div class="offset1 span7 content" style="margin-bottom:60px;text-align:justify;">
-
                <img style="height:150px;" src="https://static.igem.org/mediawiki/2013/c/ca/Calibrate_logo.jpg" />
+
<i>Caenorhabditis elegans</i> has impressive chemotaxis behaviour which is naturally used to seek out food sources. It has been shown to respond to a wide range of both water-soluble and volatile chemicals as either attractants or repellants with a GPCR system.
-
                <img style="height:150px;" src="https://static.igem.org/mediawiki/2013/6/60/Qubit_logo.jpg" />
+
<br><br>
-
                <img style="height:80px;" src="https://static.igem.org/mediawiki/2013/5/5b/Conocophillips_logo.jpg" />
+
In order to test the effectiveness of our part, it was necessary to create an assay to test our completed part against. Using the assay methodology pioneered by QGEM 2011 (Margie et. al. 2013), worms were placed in a common starting area and their movement in response to a control substance and to the test odorant was observed. With an anaesthetic at target sites to immobilize worms at the end of each trial, the number of worms in the test and control quadrants were counted to calculate a chemotactic index. More details on how this assay works can be outlined<a href="http://www.jove.com/video/50069/c-elegans-chemotaxis-assay"> here</a>.
-
        </div>
+
<br><br>
-
    </div>
+
Isovaleric acid solutions at 1M, 7:1, and 99% concentrations were used. A total of 38 chemotaxis assay plates were run. The graph to the right shows our results from the standard graph for our chemotaxis assay. According to statistical analysis, there was no significant difference between <i>C. elegans</i> motility response to the control and test samples.  
 +
</div>
 +
  <div class="span4">
 +
                <img style="height:500px;text-align:center;" src = "https://static.igem.org/mediawiki/igem.org/c/c5/Chemotaxisboxplots.jpg"/>
 +
        </div>
</div>
</div>
 +
<br>
 +
<br>
 +
<br>
</body>
</body>
</html>
</html>

Latest revision as of 00:24, 28 September 2013

Untitled Document

QGEM 2013 PRESENTS:
Mosquito Repellent
Our idea of a mosquito repellent aims to neutralize the odours that mosquitoes are attracted to. Recent studies have shown that mosquitoes infected with the malarial parasite, Plasmodium falciparum, are four times more attracted to foot odour than non-infected mosquitoes. By removing the volatile compounds that cause these smells, we hypothesize that this will effectively decrease the ability of mosquitoes to find humans. Our project thus focuses on creating a genetic and enzymatic pathway to remove those volatile compounds. It begins with the uptake of isovaleric acid, a known mosquito semiochemical that is present is foot odour, and converts it into banana smell. Domestically, this serves as a foot deodorant but on a global scale it may also curb malaria infection rates.
AtoE
AtoE is a non-specific membrane transporter of short-chain fatty acids endogenously expressed in ''E.coli''. High constitutive expression of this gene would allow high intake of surrounding isovaleric acid and channelling into the breakdown pathway.

In order to isolate the gene from the E. coli genome, we designed PCR primers so that the AtoE gene could be replicated with the correct biobrick prefix and suffix. The size of the AtoE gene is 1323 bp, but with the addition of the standard biobrick cut sites (43bp), a 1.4kb band was expected and was seen on the gel of the PCR products (on right).
NCAR and NPT
Carboxylic acid reductase (CAR) and phosphopantetheinyl transferase (NPT) are endogenously expressed in Nocardia iowensis. NCAR is a highly non-specific carboxylic acid reductase that converts fatty acids such as isovaleric acid into aldehydes. NPT is an enzyme that induces a post-translational modification by adding a pantetheinyl arm to the active site of the carboxylic acid reductase, which is crucial for the formation of a thioester intermediate. NCAR was submitted as a single part by Calgary iGEM 2012, but it is dependent on NPT for full function. We thus sought to link these two enzymes together to improve Calgary's part.
YjgB
YjgB is a non-specific zinc-containing alcohol dehydrogenase endogenously expressed in E. coli. It reduces a number of different aldehydes to their corresponding alcohol using NADPH as a co-substrate. In this instance, we planned to use yjgB to reduce isoamyl aldehyde to isoamyl alcohol. We were successful in amplifying yjgB by PCR, cloning it into pSB1C3 with a high constitutive expression cassette, producing high concentrations of protein at the predicted size of 36kDa on an SDS PAGE gel. We verified our biobrick before sending it into the registry and found the sequence to be an exact match for the putative sequence from GenBank. Over the next week we will be using mass spectrometry and an NADPH activity assay to verify the amino acid sequence of the part and quantify its specific activity towards isobutyraldehyde. This is the part we have submitted this year. More details on this can be found on the Parts page on the wiki.
ATF1
Alcohol acetyl-transferase 1 (ATF1) (BBa_J45014) is an enzyme endogenous to Saccharomyces cerevisiae and was first used by MIT iGEM 2006. It catalyzes the conversion of isoamyl alcohol to isoamyl acetate, which has a banana smell. This will complete the neutralization of isovaleric acid. We received the ATF1 gene from the Biobrick registry where we transformed and cut the part to be placed in with other genes in our pathway.
Testing Isovaleric Acid
Caenorhabditis elegans has impressive chemotaxis behaviour which is naturally used to seek out food sources. It has been shown to respond to a wide range of both water-soluble and volatile chemicals as either attractants or repellants with a GPCR system.

In order to test the effectiveness of our part, it was necessary to create an assay to test our completed part against. Using the assay methodology pioneered by QGEM 2011 (Margie et. al. 2013), worms were placed in a common starting area and their movement in response to a control substance and to the test odorant was observed. With an anaesthetic at target sites to immobilize worms at the end of each trial, the number of worms in the test and control quadrants were counted to calculate a chemotactic index. More details on how this assay works can be outlined here.

Isovaleric acid solutions at 1M, 7:1, and 99% concentrations were used. A total of 38 chemotaxis assay plates were run. The graph to the right shows our results from the standard graph for our chemotaxis assay. According to statistical analysis, there was no significant difference between C. elegans motility response to the control and test samples.